{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:27:40Z","timestamp":1791260860779,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22JC1403002"],"award-info":[{"award-number":["22JC1403002"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["YWP2023-001"],"award-info":[{"award-number":["YWP2023-001"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400645"],"award-info":[{"award-number":["81400645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00428-025-04067-9","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:36:03Z","timestamp":1744133763000},"page":"1103-1115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["FGFR2 fusion\/rearrangement analysis in intrahepatic cholangiocarcinoma using DNA\/RNA-based NGS and FISH"],"prefix":"10.1007","volume":"487","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-9082","authenticated-orcid":false,"given":"Yuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"4067_CR1","doi-asserted-by":"crossref","unstructured":"Lin J, Zhang H, Yu H, Bi X, Zhang W, Yin J et al (2022) Epidemiological characteristics of primary liver cancer in Mainland China From 2003 to 2020: a representative multicenter study. Front Oncol 12:906778","DOI":"10.3389\/fonc.2022.906778"},{"issue":"2","key":"4067_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21037\/hbsn.2017.01.06","volume":"6","author":"K Wang","year":"2017","unstructured":"Wang K, Zhang H, Xia Y, Liu J, Shen F (2017) Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 6(2):79\u201390","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"10272","key":"4067_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh D-Y, Zhu AX (2021) Biliary tract cancer. Lancet 397(10272):428\u2013444","journal-title":"Lancet"},{"issue":"1","key":"4067_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21037\/hbsn-21-75","volume":"12","author":"L An","year":"2023","unstructured":"An L, Zheng R, Zhang S, Chen R, Wang S, Sun K et al (2023) Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries. Hepatobiliary Surg Nutr 12(1):45\u201355","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"4067_CR5","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/hep.30289","volume":"69","author":"AE Sirica","year":"2019","unstructured":"Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X et al (2019) Intrahepatic cholangiocarcinoma: continuing challenges and translational advances. Hepatology 69(4):1803\u20131815","journal-title":"Hepatology"},{"issue":"7","key":"4067_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hepr.12605","volume":"46","author":"S Mosadeghi","year":"2016","unstructured":"Mosadeghi S, Liu B, Bhuket T, Wong RJ (2016) Sex-specific and race\/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: an updated analysis of the 2000\u20132011 Surveillance, Epidemiology and End Results registry. Hepatol Res 46(7):669\u2013677","journal-title":"Hepatol Res"},{"issue":"7","key":"4067_CR7","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/jnci\/djad046","volume":"115","author":"K Spencer","year":"2023","unstructured":"Spencer K, Pappas L, Baiev I, Maurer J, Bocobo AG, Zhang K et al (2023) Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. J Natl Cancer Inst 115(7):870\u2013880","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4067_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2016.2620","volume":"38","author":"M Katoh","year":"2016","unstructured":"Katoh M (2016) FGFR inhibitors: effects on cancer cells, tumor microenvironment and whole-body homeostasis (review). Int J Mol Med 38(1):3\u201315","journal-title":"Int J Mol Med"},{"issue":"10","key":"4067_CR9","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/2159-8290.CD-20-1669","volume":"11","author":"JM Cleary","year":"2021","unstructured":"Cleary JM, Raghavan S, Wu Q, Li YY, Spurr LF, Gupta HV et al (2021) FGFR2 extracellular domain in-frame deletions are therapeutically targetable genomic alterations that function as oncogenic drivers in cholangiocarcinoma. Cancer Discov 11(10):2488\u20132505","journal-title":"Cancer Discov"},{"issue":"12","key":"4067_CR10","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1158\/1078-0432.CCR-14-2329","volume":"21","author":"M Touat","year":"2015","unstructured":"Touat M, Ileana E, Postel-Vinay S, Andr\u00e9 F, Soria J-C (2015) Targeting FGFR signaling in cancer. Clin Cancer Res 21(12):2684\u20132694","journal-title":"Clin Cancer Res"},{"issue":"9","key":"4067_CR11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M et al (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003\u20131010","journal-title":"Nat Genet"},{"issue":"1","key":"4067_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12967-020-02437-2","volume":"18","author":"L Wang","year":"2020","unstructured":"Wang L, Zhu H, Zhao Y, Pan Q, Mao A, Zhu W et al (2020) Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience. J Transl Med 18(1):273","journal-title":"J Transl Med"},{"issue":"4","key":"4067_CR13","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/hep.26890","volume":"59","author":"Y Arai","year":"2014","unstructured":"Arai Y, Totoki Y, Hosoda F, Shirota T, Hama N, Nakamura H et al (2014) Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology 59(4):1427\u20131434","journal-title":"Hepatology"},{"key":"4067_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/PO.18.00414","volume":"4","author":"J Cao","year":"2020","unstructured":"Cao J, Hu J, Liu S, Meric-Bernstam F, Abdel-Wahab R, Xu J et al (2020) Intrahepatic cholangiocarcinoma: genomic heterogeneity between eastern and western patients. JCO Precis Oncol 4:557\u2013569","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"4067_CR15","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1038\/ncomms7087","volume":"6","author":"D Sia","year":"2015","unstructured":"Sia D, Losic B, Moeini A, Cabellos L, Hao K, Revill K et al (2015) Massive parallel sequencing uncovers actionable FGFR2\u2013PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. Nat Commun 6(1):6087","journal-title":"Nat Commun"},{"issue":"5","key":"4067_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R et al (2020) Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol 21(5):671\u2013684","journal-title":"Lancet Oncol"},{"issue":"1","key":"4067_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, Lu D, Chen R, Lin Y, Zhu H, Zhang Z et al (2022) Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell 40(1):70-87.e15","journal-title":"Cancer Cell"},{"key":"4067_CR18","doi-asserted-by":"crossref","unstructured":"Benson AB, D\u2019Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA et al (2023) NCCN Guidelines\u00ae Insights: Biliary Tract Cancers, Version 2.2023. J Natl Compr Cancer Netw 21(7):694\u2013704","DOI":"10.6004\/jnccn.2023.0035"},{"issue":"6","key":"4067_CR19","first-page":"1355","volume":"11","author":"Y Zou","year":"2023","unstructured":"Zou Y, Zhu K, Pang Y, Han J, Zhang X, Jiang Z et al (2023) Molecular detection of FGFR2 rearrangements in resected intrahepatic cholangiocarcinomas: FISH could be an ideal method in patients with histological small duct subtype. J Clin Transl Hepatol 11(6):1355\u20131367","journal-title":"J Clin Transl Hepatol"},{"issue":"18","key":"4067_CR20","first-page":"i333","volume":"28","author":"T Rausch","year":"2012","unstructured":"Rausch T, Zichner T, Schlattl A, St\u00fctz AM, Benes V, Korbel JO (2012) DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics (Oxford, England) 28(18):i333\u2013i339","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"9","key":"4067_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s40265-020-01330-y","volume":"80","author":"SM Hoy","year":"2020","unstructured":"Hoy SM (2020) Pemigatinib: first approval. Drugs 80(9):923\u2013929","journal-title":"Drugs"},{"issue":"5","key":"4067_CR22","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1177\/10781552231171079","volume":"29","author":"E Lodl","year":"2023","unstructured":"Lodl E, Ramnaraign B, Sahin I, Wheeler S (2023) Updates in the use of targeted therapies for the treatment of cholangiocarcinoma. J Oncol Pharm Pract 29(5):1206\u20131217","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"4067_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16(2):139\u2013149","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"4067_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41419-021-03548-4","volume":"12","author":"X Pu","year":"2021","unstructured":"Pu X, Ye Q, Cai J, Yang X, Fu Y, Fan X et al (2021) Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas. Cell Death Dis 12(3):256","journal-title":"Cell Death Dis"},{"issue":"8","key":"4067_CR25","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41416-022-01908-1","volume":"127","author":"O Neumann","year":"2022","unstructured":"Neumann O, Burn TC, Allg\u00e4uer M, Ball M, Kirchner M, Albrecht T et al (2022) Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. Br J Cancer 127(8):1540\u20131549","journal-title":"Br J Cancer"},{"issue":"9","key":"4067_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cancers11091309","volume":"11","author":"M Kirchner","year":"2019","unstructured":"Kirchner M, Neumann O, Volckmar AL, St\u00f6gbauer F, Allg\u00e4uer M, Kazdal D et al (2019) RNA-based detection of gene fusions in formalin-fixed and paraffin-embedded solid cancer samples. Cancers 11(9):1309","journal-title":"Cancers"},{"issue":"2","key":"4067_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jmoldx.2018.10.003","volume":"21","author":"RA Blidner","year":"2019","unstructured":"Blidner RA, Haynes BC, Hyter S, Schmitt S, Pessetto ZY, Godwin AK et al (2019) Design, optimization, and multisite evaluation of a targeted next-generation sequencing assay system for chimeric RNAs from gene fusions and exon-skipping events in non-small cell lung cancer. J Mol Diagn 21(2):352\u2013365","journal-title":"J Mol Diagn"},{"key":"4067_CR28","doi-asserted-by":"publisher","first-page":"e00173","DOI":"10.1016\/j.plabm.2020.e00173","volume":"21","author":"S Barua","year":"2020","unstructured":"Barua S, Wang G, Mansukhani M, Hsiao S, Fernandes H (2020) Key considerations for comprehensive validation of an RNA fusion NGS panel. Pract Lab Med 21:e00173","journal-title":"Pract Lab Med"},{"issue":"6","key":"4067_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jmoldx.2011.06.007","volume":"13","author":"DL Evers","year":"2011","unstructured":"Evers DL, He J, Kim YH, Mason JT, O\u2019Leary TJ (2011) Paraffin embedding contributes to RNA aggregation, reduced RNA yield, and low RNA quality. J Mol Diagn 13(6):687\u2013694","journal-title":"J Mol Diagn"},{"issue":"10","key":"4067_CR30","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jtho.2018.05.041","volume":"13","author":"KD Davies","year":"2018","unstructured":"Davies KD, Le AT, Sheren J, Nijmeh H, Gowan K, Jones KL et al (2018) Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples. J Thora Oncol 13(10):1474\u20131482","journal-title":"J Thora Oncol"},{"key":"4067_CR31","doi-asserted-by":"crossref","unstructured":"Egan JB, Marks DL, Hogenson TL, Vrabel AM, Sigafoos AN, Tolosa EJ et al (2017) Molecular modeling and functional analysis of exome sequencing-derived variants of unknown significance identify a novel, constitutively active FGFR2 mutant in cholangiocarcinoma. JCO Precis Oncol 2017:PO.17.00018","DOI":"10.1200\/PO.17.00018"},{"issue":"11","key":"4067_CR32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/13543784.2021.1995355","volume":"30","author":"S Braun","year":"2021","unstructured":"Braun S, McSheehy P, Litherland K, McKernan P, Forster-Gross N, Bachmann F et al (2021) Derazantinib: an investigational drug for the treatment of cholangiocarcinoma. Expert Opin Investig Drugs 30(11):1071\u20131080","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"4067_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2159-8290.CD-20-0766","volume":"11","author":"IM Silverman","year":"2021","unstructured":"Silverman IM, Hollebecque A, Friboulet L, Owens S, Newton RC, Zhen H et al (2021) Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib. Cancer Discov 11(2):326\u2013339","journal-title":"Cancer Discov"},{"issue":"5","key":"4067_CR34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/humrep\/14.5.1213","volume":"14","author":"MI Evans","year":"1999","unstructured":"Evans MI, Henry GP, Miller WA, Bui TH, Snidjers RJ, Wapner RJ et al (1999) International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used. Hum Reprod (Oxford, England) 14(5):1213\u20131216","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"8","key":"4067_CR35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","volume":"40","author":"A Hayashi","year":"2016","unstructured":"Hayashi A, Misumi K, Shibahara J, Arita J, Sakamoto Y, Hasegawa K et al (2016) Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma. Am J Surg Pathol 40(8):1021\u20131030","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4067_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/his.14417","volume":"79","author":"H Nguyen Canh","year":"2021","unstructured":"Nguyen Canh H, Takahashi K, Yamamura M, Li Z, Sato Y, Yoshimura K et al (2021) Diversity in cell differentiation, histology, phenotype and vasculature of mass-forming intrahepatic cholangiocarcinomas. Histopathology 79(5):731\u2013750","journal-title":"Histopathology"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04067-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04067-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04067-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:21:42Z","timestamp":1764055302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04067-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4067"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04067-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients were exempted from signing informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by the Institutional Ethics Committee of Zhongshan Hospital, Fudan University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}